BlockBeats news, August 5, MEI Pharma (NASDAQ: MEIP) today announced that it has acquired 929,548 Litecoin (LTC) at an average purchase price of $107.58 per coin, successfully launching a significant institutional treasury strategy.
As of August 4, 2025, the total value of this LTC treasury is approximately $110.4 million. MEI thus becomes the first U.S. publicly traded company to use Litecoin as a primary reserve asset, initiating a new strategy based on digital asset infrastructure and long-term capital innovation.
This strategic initiative was developed in collaboration with GSR and completed under the guidance of Charlie Lee, the founder of Litecoin and a member of the MEI board. This move marks the starting point of a larger institutional treasury plan by MEI, aimed at leveraging the scalability and reliability of Litecoin as a long-term store of value and operating capital asset.
